Prothena Corp Public (PRTA) Amortizatization of Intangibles (2019 - 2022)
Prothena Corp Public's (PRTA) quarterly Amortizatization of Intangibles came in at $1.5 million in Q2 2022, up 4.24% year-on-year from $1.4 million in Q2 2021, and up 1.1% quarter-over-quarter from $1.5 million in Q1 2022.
Prothena Corp Public (PRTA) Amortizatization of Intangibles (2019 - 2022) Analysis & Trends
Prothena Corp Public's Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at $1.5 million for Q2 2022.
- On a quarterly basis, Amortizatization of Intangibles rose 4.24% year-over-year to $1.5 million in Q2 2022; TTM through Jun 2022 was $5.8 million, a 4.18% increase from a year earlier, with the FY2021 full-year figure at $5.7 million, up 4.12% from the prior year.
- Amortizatization of Intangibles advanced to $1.5 million in Q2 2022 per PRTA's latest filing, from $1.5 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.5 million in Q2 2022 and bottomed at $1.3 million in Q1 2019.
- The 4-year median for Amortizatization of Intangibles is $1.4 million (2020), against an average of $1.4 million.
- Across the five-year window, Amortizatization of Intangibles climbed 3.78% in 2020 and increased 4.24% in 2022, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $1.3 million in 2019, then increased by 3.98% to $1.4 million in 2020, then advanced by 4.18% to $1.4 million in 2021, then gained by 2.15% to $1.5 million in 2022.
- Per Business Quant, the three latest PRTA Amortizatization of Intangibles figures stand at $1.5 million (Q2 2022), $1.5 million (Q1 2022), and $1.4 million (Q4 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Prothena Corp Public | 471.02 Mn | 141.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 1.48 Mn |
| Jun 30, 2022 | 1.48 Mn |
| Mar 31, 2022 | 1.46 Mn |
| Mar 31, 2022 | 1.46 Mn |
| Dec 31, 2021 | 1.44 Mn |
| Dec 31, 2021 | 1.44 Mn |
| Sep 30, 2021 | 1.43 Mn |
| Sep 30, 2021 | 1.43 Mn |
| Jun 30, 2021 | 1.42 Mn |
| Jun 30, 2021 | 1.42 Mn |
| Mar 31, 2021 | 1.40 Mn |
| Mar 31, 2021 | 1.40 Mn |
| Dec 31, 2020 | 1.39 Mn |
| Dec 31, 2020 | 1.39 Mn |
| Sep 30, 2020 | 1.37 Mn |
| Sep 30, 2020 | 1.37 Mn |
| Jun 30, 2020 | 1.36 Mn |
| Jun 30, 2020 | 1.36 Mn |
| Mar 31, 2020 | 1.35 Mn |
| Mar 31, 2020 | 1.35 Mn |